AB Corporate Bond ETF (NASDAQ:EYEG) Shares Shorted: Short Interest Down 89.5% in September

AB Corporate Bond ETF (NASDAQ:EYEG – Get Free Report) was the target of a significant decline in short interest in September. As of September 15th, there was short interest totaling 109 shares, a decline of 89.5% from the August 31st total of 1,040 shares. Approximately 0.0% of the company’s shares are sold short. Based on an average trading volume of 461 shares, the short-interest ratio is presently 0.2 days.

AB Corporate Bond ETF Price Performance

EYEG stock opened at $33.70 on Friday. The firm has a 50-day moving average of $34.45 and a 200 day moving average of $34.95. The company has a debt-to-equity ratio of 0.01, a current ratio of 3.07 and a quick ratio of 3.07. The company has a market cap of $26.96 million, a P/E ratio of -20.06 and a beta of 0.18. AB Corporate Bond ETF has a 1 year low of $33.64 and a 1 year high of $36.63.

AB Corporate Bond ETF Cuts Dividend

The firm also recently announced a monthly dividend, which was paid on Friday, September 4th. Stockholders of record on Tuesday, September 1st were given a $0.1284 dividend. The ex-dividend date of this dividend was Tuesday, September 1st. This represents a $1.54 dividend on an annualized basis and a dividend yield of 4.6%. This is a drop from AB Corporate Bond ETF’s previous monthly dividend of $0.1427. AB Corporate Bond ETF’s payout ratio is currently -101.79%.

About AB Corporate Bond ETF

(Get Free Report)

EyeGate Pharmaceuticals, Inc is a clinical stage specialty pharmaceutical company, which engages in the development and commercialization of products for treating diseases and disorders of the eye. Its pipeline includes MoxiGel and Ocular Bandage Gel. The company was founded in 1998 and is headquartered in Waltham, MA.

See Also

Receive News & Ratings for AB Corporate Bond ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AB Corporate Bond ETF and related companies with MarketBeat.com's FREE daily email newsletter.